. Predicted kinases for specific phosphorylation sites using in silico approaches. We used 7 different methods for which web-based tools are available to predict the most likely kinases for each of the phosphorylation sites used in KiPIK screening. Expected kinases are shown in red, and closely related kinases in green. None of the approaches was consistently able to predict the correct kinase. For example, although many methods identified EGFR as the likely kinase for EGFR Y1016ph, two of the methods failed to place this kinase in the top three (NetPhos 3.1, and PhosphoNET). None of the methods was able to place Haspin/GSG2 in the top ten places for H3T3ph. For each phosphosite, the number of predictions that placed the correct kinase(s) as the top candidate were: H3T3ph, 0/7; H3S28ph, 1/7; Integrin b1A Y795ph, 0/7; EGFR Y1016ph, 4/7; INCENP S446ph, 2/7; BCL9L S915ph, 4/7. This failure rate occurs even when the expected kinase is available to the prediction algorithms at high frequency: Haspin, 1/7; Aurora family, 6/7; Src family, 7/7; EGFR, 7/7; Cdk1, 7/7; PKA 7/7. KinasePhos 2.0 (http://kinasephos2.mbc.nctu.edu.tw/index.html) uses sequence-based amino acid coupling pattern analysis and solvent accessibility in a SVM (support vector machine). Validated sites from the phospho.ELM and Swiss-Prot databases were used for training. Predictions can be made for 58 human protein kinases. The higher the score, the more likely the residue is phosphorylated 9 .
NetPhos 3.1 (http://www.cbs.dtu.dk/services/NetPhos/) predicts phosphorylation sites using neural networks based on phosphorylation sites in the phospho.ELM database. Predictions are made for 17 kinases: ATM, CKI/CSNK1, CKII/CSNK2, CaM-II/CAMK2, DNAPK/PRKDC, EGFR, GSK3, INSR, PKA, PKB/AKT, PKC, PKG, RSK, SRC, CDC2/CDK1, CDK5 and p38MAPK. Output scores are in the range 0 to 1; scores above 0.5 indicate "positive predictions" 10 . NetPhorest 2.1 (http://www.netphorest.info/index.shtml) uses a collection of probabilistic classifiers based on position-specific scoring matrices (PSSM) or neural networks to classify phosphorylation sites according to the likely kinase responsible. It assumes that kinases that are on a similar branch of a sequence-based dendrogram have similar substrates and makes predictions for approximately 70 subgroups covering 222 kinases. Scores are from 0 to 1, with high scores being more confident predictions 11, 12 . NetworKIN 3.0 (http://www.networkin.info/index.shtml) builds on NetPhorest by including contextual information on kinases and substrates from the STRING database, such as binding interactions or substrates that have other residues that are already known targets of a kinase. The theoretically neutral score is 1, and the higher the score for a given kinase, the higher the likelihood it is indeed the kinase. Kinome coverage is as for NetPhorest 2.1. Note that CDK1 is a strong "hit" for INCENP S446ph in part because the STRING database recognises that other INCENP residues are known targets for this kinase 12, 13 . PHOSIDA (http://141.61.102.18/phosida/index.aspx) includes the simple Motif Matcher tool that searches for sequence matches with annotated kinase recognition patterns for 33 motifs covering 25 kinases. No score is provided 14 . PhosphoNET (http://www.phosphonet.ca) includes Kinase Predictor V2 that makes predictions based on determinants of specificity (DoS) within the primary amino acid sequences of the catalytic domains of 488 human protein kinases. The higher the score, the better the prospect that a kinase will phosphorylate a given site, with a maximum possible score of 1000 (ref. 15 ). ScanSite 4.0 (https://scansite4.mit.edu/4.0/#home). Phosphorylation sites for particular kinases are predicted using PSSMs determined from oriented peptide library techniques. Thirty-three motifs covering 31 human kinases are included. Scores are on a scale of 0 to infinity, where 0 means a protein sequence perfectly matches the optimal binding pattern, and larger numbers indicate progressively poorer matches to the optimal consensus sequence 16,17 .
